Danske Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Danske Bank's BMY Position: Q3 2026 in Review
Danske Bank increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q3 2026, buying an estimated $3.36M and bringing the position to 1,554,366 shares worth $97M. The position accounts for 0.19% of the portfolio, ranked #94.
Danske Bank first reported a position in BMY in Q1 2024 and has held it in 11 quarters since. The position peaked at $101M in Q1 2025. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Danske Bank held 1,554,366 shares of Bristol-Myers Squibb worth $97M as of Q3 2026.
- Danske Bank bought 53,233 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.36M.
- Bristol-Myers Squibb made up 0.19% of Danske Bank's portfolio in Q3 2026, its #94 holding.
- Danske Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 11 quarters since.
- Danske Bank's Bristol-Myers Squibb position peaked at $101M in Q1 2025.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.